Roundup Settlement Expected Before Christmas, Bayer CEO Says

German drugs and agrochemicals group Bayer is expecting a $7.25 billion settlement on its Roundup weedkiller to come before Christmas, CEO Bill Anderson said on Tuesday.

Related: Bayer Wins Roundup Trial as Settlement Decision Looms

The company is seeking to resolve tens of thousands of Roundup lawsuits through the proposed settlement, which is under review by a Missouri state court judge in St. Louis.

• “It could be any week now,” Anderson said in a press call following the company’s results, adding there would be a much smaller number of individual cases after the settlement.
• Bayer is facing approximately 65,000 claims in US state and federal courts from plaintiffs who say they developed non-Hodgkin lymphoma and other forms of cancer after using Roundup at home or on the job.
• Following a Supreme Court victory in June, Bayer moved its US Roundup business into a unit dubbed Ruveon and internally separated it from the rest of the organization.
• Bayer has said that decades of studies have shown glyphosate, Roundup’s active ingredient, is safe and does not cause cancer.

(Reporting by Veyet in Gdansk; editing by Thomas Seythal)